1 Estrogens are used as drugs and estrogen exposure is a risk factor for hormone-dependent diseases such as breast cancer. Sulfate conjugation is an important pathway for estrogen metabolism. The sulfotransferase (SULT) enzyme SULT1E1 has the lowest K m values for estrogens and catecholestrogens of the 10 known human SULT isoforms. 2 We previously cloned and characterized the human SULT1E1 cDNA and gene as steps toward pharmacogenetic studies. In the present experiments, we set out to determine whether common, functionally significant genetic polymorphisms might exist for SULT1E1. As a first step, we 'resequenced' the eight SULT1E1 exons and exon -intron splice junctions as well as portions of the 5 0 -flanking region using DNA from 60 African-American and 60 Caucasian-American subjects. 3 In all, 23 polymorphisms, 22 single nucleotide polymorphisms (SNPs) and one insertion deletion were observed. There were three nonsynonymous coding SNPs (cSNPs) that altered the following encoded amino acids: Asp22Tyr, Ala32Val and Pro253His. Among these, 12 pairs of SNPs were tightly linked. In addition, 12 unambiguous SULT1E1 haplotypes were identified, including six that were common to both populations studied. 4 Transient expression in COS-1 cells of constructs containing the three nonsynonymous cSNPs showed significant decreases in SULT1E1 activity for the Tyr22 and Val32 allozymes, with corresponding decreases in levels of immunoreactive protein. There were no changes in levels of either activity or immunoreactive protein for the His253 allozyme. Apparent K m values of the Val32 allozyme for the two cosubstrates for the reaction, 17b-estradiol and 3 0 -phosphoadenosine 5 0 -phosphosulfate, were not significantly different from those of the wild-type enzyme, but there was a two-to three-fold increase in K m values for the His253 allozyme and a greater than five-fold increase for the Tyr22 allozyme. 5 These observations raise the possibility that genetically determined variation in SULT1E1-catalyzed estrogen sulfation might contribute to the pathophysiology of estrogen-dependent diseases as well as variation in the biotransformation of exogenously administered estrogens.
Introduction
Estrogens are used as therapeutic agents and exposure to these steroids is a risk factor for the development of hormonedependent disease (Colditz, 1996; Henderson & Bernstein, 1996) . A major pathway for estrogen metabolism in humans is sulfate conjugation catalyzed by sulfotransferase (SULT) enzymes (Hobkirk, 1993; Aksoy et al., 1994; Falany et al., 1995) . Steroid sulfation can potentially contribute to the control of levels of biologically active hormone in target tissues; it might also form a hormone 'reservoir' after the hydrolysis of sulfate conjugates by sulfatases (Pasqualini & Chetrite, 1996) , and it enhances the water solubility -and thus the renal excretion -of steroids (Hobkirk, 1993; Strott, 1996) . In all, 10 SULT isoforms are known to be expressed in human tissue. These enzymes catalyze the transfer of a sulfuryl group from 3 0 -phosphoadenosine 5 0 -phosphosulfate (PAPS) to an acceptor substrate. SULT1E1 catalyzes the sulfate conjugation of estrone (E1), 17b-estradiol (E2), catecholestrogens and 2-methoxyestradiol with the lowest K m values -in the nm rangeof the 10 known human SULT isoforms (Falany et al., 1995; Zhang et al., 1998; Adjei et al., 2001; Adjei & Weinshilboum, 2002) . As a result, SULT1E1 is able to catalyze the sulfation of physiological concentrations of estrogens (Pasqualini & Chetrite, 1996) . SULT1E1 is expressed in many human tissues including liver and jejunum (Aksoy et al., 1994; Her et al., 1996) , mammary epithelium cells (Falany & Falany, 1996; Qian et al., 1998) , endometrium and testis (Song et al., 1995; 1997; Qian & Song, 1999) .
We previously cloned and characterized the human SULT1E1 cDNA and gene (Aksoy et al., 1994; Her et al., 1995) as steps toward studies of possible inherited variation in estrogen sulfation. The human SULT1E1 gene is approximately 20 kb in length, consists of eight exons and maps to chromosome 4q13 (Her et al., 1995) . We also reported large individual variations in levels of SULT1E1 immunoreactive protein in the small intestine . Large individual variations were also observed in human liver samples . In the present experiments, we have applied a genotype-to-phenotype strategy to determine whether SULT1E1, like the genes encoding other human SULT isoforms Freimuth et al., 2001 ; Thomae et al., 2002) , might contain common, functionally significant genetic polymorphisms. Specifically, we resequenced SULT1E1 using DNA from 60 African-American and 60 Caucasian-American subjects and observed 23 polymorphisms, including three nonsynonymous cSNPs -one in DNA from an African-American and two in DNA from CaucasianAmerican subjects. We then created expression constructs for these nonsynonymous cSNPs and performed functional genomic studies of recombinant allozymes encoded by these variant alleles. Those results showed decreased levels of basal activity and decreased levels of immunoreactive protein for two of the three variant allozymes, as compared with the wildtype enzyme. Substrate kinetic studies also showed differences in apparent K m and V max /K m ratios for two of the variant allozymes. These results raise the possibility of inherited variation in the SULT1E1-catalyzed sulfate conjugation of estrogens and structurally related steroid compounds.
Methods

DNA samples
DNA from 60 African-American and 60 Caucasian-American subjects was obtained from the Coriell Cell Repository (Camden, NJ, U.S.A.). Specifically, 60 samples each from the two 100-item sample sets, HD100AA and HD100CAU, were used to perform these experiments. All of the DNA samples had been anonymized by the National Institutes of Health prior to their deposit in the Coriell Cell Repository, and all subjects had provided written consent for the use of their DNA for experimental purposes. The present studies were reviewed and approved by the Mayo Clinic Institutional Review Board.
SULT1E1 resequencing
To make it possible to amplify all SULT1E1 exons and splice junctions as well as a portion of the 5 0 -flanking region of the gene, eight separate PCR amplifications were performed with each of the 120 DNA samples studied. M13 'tags' were added to the 5 0 -ends of each primer to make it possible to use dyeprimer DNA-sequencing chemistry to facilitate the identification of heterozygous bases (Chadwick et al., 1996) . Primers were designed to hybridize within introns, within the 5 0 -flanking region or within the 3 0 -untranslated region of the terminal exon at locations selected to avoid repetitive sequence. Sequences of all primers used in these and subsequent experiments are listed in Table 1 . Amplification reactions were performed with AmpliTaq Gold DNA polymerase (Perkin-Elmer, Foster City, CA, U.S.A.) with a 'hot start' to help ensure amplification specificity. The 50 ml reaction mixture contained 2.5 U of DNA polymerase, 5 ml of a 10-fold diluted DNA sample (160 -190 ng DNA), 12.5 pmol of each primer (7 pmol for exon 7), 0.05 mm dNTP (Boehringer Mannheim, Indianapolis, IN, U.S.A.) and 5 ml of 10 Â PCR buffer containing 15 mm MgCl 2 (Perkin-Elmer). PCR cycling parameters involved a 12 min 'hot start' at 941C, followed by 35 cycles (40 cycles for exon 7) of 941C for 30 s, 551C (681C for the exon 7) for 30 s and 45 s at 721C -with a final 10 min extension at 721C. All reactions were performed in a Perkin-Elmer model 9700 thermal cycler. Amplicons were sequenced on both strands in the Mayo Molecular Core Facility with an ABI 377 DNA sequencer using BigDye TM (Perkin-Elmer) dye primer-sequencing chemistry. To exclude PCR-induced artefacts, independent amplifications were performed for those samples in which a SNP was observed only once or for any sample with an ambiguous chromatogram. Chromatograms were analyzed using the PolyPhred 3.0 (Nickerson et al., 1997) and Consed 8.0 (Gordon et al., 1998) programs from the University of Washington. The University of Wisconsin GCG software package, Version 10, was also used to analyze nucleotide sequence. GenBank accession numbers for the SULT1E1 reference sequences used in these experiments were U20514 -U20521 (Her et al., 1995) .
Expression constructs and transient expression
Site-directed mutagenesis was performed using the QuickChange kit (Stratagene, La Jolla, CA, U.S.A.) to create DNA constructs for alleles containing the three SULT1E1 nonsynonymous cSNPs observed during the resequencing experiments. Primer sequences used to create those constructs are listed in Table 1 . Sequences of the constructs were confirmed by sequencing both strands after cloning them into the eukaryotic expression vector pCR3.1 (Invitrogen, Carlsbad, CA, U.S.A.). Expression constructs for the SULT1E1 wildtype and variant cDNAs, as well as 'empty' pCR3.1 that lacked an insert, were then transfected into COS-1 cells in serum-free Dulbecco's modified Eagles medium (DMEM) (BioWhittaker, Walkersville, MD, U.S.A.) using the TransFast reagent (Promega, Madison, WI, U.S.A.), as suggested by the manufacturer, at a charge ratio of 1 : 1. Construct DNA (7 mg) was cotransfected with 7 mg of pSV-b-galactosidase DNA (Promega) as a control to make it possible to correct for transfection efficiency. After 48 h, the COS-1 cells were harvested in 5 mm potassium phosphate buffer, pH 7.5, and were homogenized with a Polytron homogenizer (Brinkmann Instruments, Westbury, NY, U.S.A.). The homogenates were centrifuged at 100,000 Â g for 1 h, and supernatant preparations were stored at À801C.
Enzyme assays, substrate kinetic and thermal stability studies Recombinant wildtype and variant allozymes were assayed for SULT1E1 enzyme activity using the method of Foldes & Meek (1973) as modified by Aksoy et al. (1994) . Specifically, 50 nm E2 served as the sulfate acceptor substrate and 0.4 mm 35 S-PAPS as the sulfate donor cosubstrate. Enzyme reactions were incubated for 20 min and included 8 mm dithiothreitol, 1.25 mm MgCl 2 and 10 mm potassium phosphate buffer, pH 6.5, in a total volume of 160 ml. Blanks were samples that did not contain E2. One unit of enzyme activity represented the formation of 1 nmol of E2 sulfate per hour of incubation at 371C. Levels of enzyme activity were corrected for transfection efficiency by measuring b-galactosidase activity using the b-galactosidase Assay System (Promega), as suggested by the manufacturer. Standard curves were constructed that ranged from 1 to 6 mU b-galactosidase activity, and all samples fell within this range. Protein concentrations were determined using the method by Bradford (1976) , and protein concentrations for COS-1 cell cytosol preparations ranged from 0.94 to 1.13 mg ml
À1
. Apparent K m values were also determined with both cosubstrates for each allozyme studied. Since SULTs can display profound substrate inhibition (Weinshilboum & Otterness, 1994) , apparent K m and V max values for E2 were determined by using a two-step process. Initial experiments used 10-fold serial dilutions of E2 that ranged from 10 À3 to 10 À9 m. Maximal activity for all allozymes was found at E2 concentrations near 100 nm. A second set of experiments was then performed in the presence of 0.4 mm PAPS using eight concentrations of E2 that varied from 3.1 to 400 nm. For the determination of apparent K m values for PAPS, seven concentrations of PAPS that ranged from 2.7 to 150 nm were assayed in the presence of 50 nm E2. Enzyme thermal stability was measured as described by Reiter et al. (1982; 1983) . Specifically, diluted COS-1 cell supernatant preparations for each of the recombinant SULT1E1 allozymes were incubated in a water bath for 15 min at temperatures that ranged from 28 to 461C. The samples were placed on ice immediately after incubation. Aliquots of the same supernatant preparations were also kept on ice as controls. Enzyme activity was then measured in both heated and unheated samples. Blank values were determined for each temperature studied.
Western blot analysis
Quantitative Western blot analyses were performed with recombinant SULT1E1 allozymes. The level of immunoreactive protein was measured using a rabbit polyclonal antibody directed against SULT1E1 amino acids 1 -13, with the addition of cysteine at the carboxy terminus. This antibody and its characteristics have been described in detail elsewhere . The quantity of COS-1 cell cytosol for each allozyme loaded on 12.5% acrylamide gels was adjusted to achieve equal b-galactosidase activity, thus correcting for transfection efficiency. Proteins were separated by SDS - A universal M13 forward sequence (5 0 -TGTAAAACGACGGCCAGT-3 0 ) was added to the 5 0 -ends of all forward primers, and a universal M13 reverse sequence (5 0 -CAGGAAACAGCTATGACC-3 0 ) was added to the 5 0 -ends of all reverse primers. Bold, italicized lower case letters in the primers are the mutated bases used to perform the site-directed mutagenesis. 'F' represents forward; 'R' reverse; 'U' upstream; 'I' intron; 'D' downstream and 'FR' flanking region. The numbering scheme for primers located in exons and the 5 0 -FR is based on the cDNA sequence, with the 'A' at the translation initiation codon designated as (+1). Positions 5 0 and 3 0 to that location were assigned negative or positive numbers, respectively. Intron-based primers were numbered on the basis of nucleotide distance from splice junctions, with (+1) as the first nucleotide at the 5 0 -end, and (À1) as the first nucleotide at the 3 0 -end of the intron. values -a method for reporting linkage data that is independent of allele frequency (Hartl & Clark, 1997; Hedrick, 2000) .
Haplotype analysis was performed by use of the E -M algorithm (Excoffier & Slatkin, 1995; Long et al., 1995) .
Results
The series of experiments described in this study began with the resequencing of SULT1E1 using 120 DNA samples obtained from the Coriell Cell Repository (Camden, NJ, U.S.A.). Of these samples, 60 were from African-American and 60 from Caucasian-American subjects. All SULT1E1 exons were resequenced, including splice junctions, as well as approximately 180 bp of the 5 0 -flanking region of the gene -an area that contains the 'TATA box'. In all, 23 polymorphisms were observed, including three nonsynonymous cSNPs. Linkage relationships and haplotypes were determined, and expression constructs were created for the wild-type and three variant allozymes encoded by alleles with the nonsynonymous cSNPs to make it possible to perform functional genomic experiments. After expression in COS-1 cells, levels of enzyme activity, levels of immunoreactive protein, substrate kinetic properties and thermal stability were determined for all four SULT1E1 recombinant allozymes. Although differences in substrate kinetics were observed, the major functional effects of changes in amino-acid sequence as a result of the cSNPs were related to the level of immunoreactive protein. These results will now make it possible to test the hypothesis that SULT1E1 genetic polymorphisms might contribute to individual variation in estrogen biotransformation and effect.
SULT1E1 resequencing and polymorphisms
The first step in this series of experiments involved resequencing SULT1E1. A total of approximately 730,000 bp of DNA sequence was analyzed for the 120 DNA samples studied. When this sequence was compared to the consensus SULT1E1 gene sequence (GenBank accession numbers U20514 -U20521), 23 polymorphisms, including one insertion -deletion and 22 SNPs, were observed in the 240 alleles resequenced ( Figure 1 and Table 2 ). In all, 18 polymorphisms were present in DNA samples from African-American, and 13 in DNA from Caucasian-American subjects. Of the SNPs, 10 in the African-American subjects were not observed in the Caucasian-American subjects, and five of those present in the Caucasian-American samples were absent in DNA from African-American subjects. In total, 13 of the 18 polymorphisms in DNA from African-American subjects and eight of the 13 in DNA from Caucasian-American subjects had frequencies greater than 1%, and, as a result, would be considered 'common' in those populations. SNPs seen in only a single DNA sample were always verified by performing a separate, independent PCR amplification, followed by sequencing.
Three nonsynonymous cSNPs were observed, each of which was present in only a single heterozygous sample. One (G64 T) was present only in DNA from an African-American subject, while the other two, C95 T and C758A, were observed in DNA samples from Caucasian-American subjects. These three cSNPs resulted in changes in encoded amino acids Asp22Tyr, Ala32Val and Pro258His, respectively. We verified the presence of these three cSNPs both by performing independent PCR amplifications, followed by DNA sequencing, and by performing RFLP assays with the same Coriell DNA samples as template for the initial PCR, followed by digestion with Hyp188III (Asp22Tyr), MwoI (Ala32Val) or DraIII (Pro253-His), respectively.
We also compared the SNPs that we observed during our resequencing studies with those present in publicly accessible databases. A total of 16 human SULT1E1 variant sequences had been deposited in the SNP database (www.ncbi.nlm.nih. gov/SNP). Of these, 15 SNPs were located in introns and one was in the 3 0 -flanking region. Only three of the SNPs, I1(69), I5(À10) and I7(À121), were observed during our resequencing studies. The remaining 13 publicly available SNPs were located in areas of genomic sequence not studied in our experiments. Iida et al. (2001) resequenced SULT1E1 using 48 DNA samples from Japanese subjects -a different ethnic group than those included in the present study. They observed 27 SNPs, but only four of the SNPs, those at nucleotide À64 in exon one, I1(69) and I1(À73) in intron one and I3(À137) in intron three were observed in our studies. These investigators did not report allele frequencies for their population (Iida et al., 2001) . The remaining SNPs reported by Iida et al. (2001) , like those deposited in dbSNP, were located in intronic areas that we did not resequence. Therefore, of the 23 SULT1E1 polymorphisms that we observed, only six -and none of the nonsynonymous cSNPs -were publicly available.
SULT1E1 linkage and haplotype analysis
We next performed linkage analysis for the various polymorphisms that we observed in SULT1E1. To do that, pairwise combinations of all 23 polymorphisms were analyzed, and D 0 values were calculated (Hartl & Clark, 1997; Hedrick, 2000) . D 0 values can range from þ 1.0 when two polymorphisms are maximally positively associated to À1.0, when two polymorphisms never occur together (Hartl & Clark, 1997; Hedrick, 2000) . The results of that analysis (Table 3) showed that if a P-value of p0.01 was selected as the 'cutoff' (Table 3) , nine and six pairs of polymorphisms were positively linked in the African-American and Caucasian-American populations, respectively, D 0 values were not calculated for the three nonsynonymous cSNPs because of their low allele frequencies.
It is becoming clear that haplotype may prove to be important for understanding functional variation as a result of genetic polymorphisms (Drysdale et al., 2000) . Therefore, we also analyzed SULT1E1 haplotypes (Table 4) . In all, 12 unambiguous haplotypes, that is, those deduced entirely on the basis of genotype, were observed in the 120 DNA samples resequenced, including 10 in African-American and eight in Caucasian-American subjects (Table 4) . These unequivocal haplotypes accounted for 89 and 92% of all samples from the two groups, respectively. Haplotype 'assignments' were then Locations, sequence alterations and frequencies of polymorphisms observed in the two populations studied are listed. The numbering scheme is that described in the legend for Table 1 . Polymorphisms within exons are boxed. I/D refers to an insertion -deletion event in which a G in the most common (wild type) allele was deleted. 
AfricanAmerican
CaucasianAmerican
Pairwise analyses were performed for SULT1E1 polymorphisms. The numbering for the locations of polymorphisms is described in the legend for Table 1 . Only polymorphism pairs that had P-values p0.01 have been listed.
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made on the basis of the encoded amino-acid sequence of the allozyme, with wildtype sequences being designated *1. We also assigned letter designations to haplotypes based on descending allele frequencies, starting with the AfricanAmerican subjects, that is, *1A was more frequent than *1B, and both were more frequent than *1C (Table 4) . We assigned *2 to the Tyr22 variant, *3 to the Val32 variant and *4 to the His253 variant even though unambiguous haplotypes could not be assigned for these samples. Finally, we were able, using the E -M algorithm (Excoffier & Slatkin, 1995; Long et al., 1995) , to infer a total of 12 and 10 additional haplotypes for DNA samples from African-American and Caucasian-American subjects, respectively. Data with regard to these additional inferred haplotypes can be obtained from the authors upon request.
Recombinant allozyme enzyme activity and Western blot analysis
We next addressed the possible functional consequences of the SULT1E1 nonsynonymous cSNPs. Expression constructs for the three SULT1E1 nonsynonymous cSNPS (ORF nucleotides 64, 95 and 758), as well as a construct with the wildtype sequence were expressed in COS-1 cells. A mammalian expression system was used in these experiments to help ensure appropriate post-translational modification as well as the presence of the mammalian protein degradation machinery. Many examples of genetic changes in a single amino acid that result in significant decreases in levels of immunoreactive protein -due in some cases to alterations in proteasomemediated protein degradation -have been reported Preuss et al., 1998; Tai et al., 1999; Freimuth et al., 2001; Thomae et al., 2002) . Two of the three recombinant SULT1E1 allozymes, Tyr22 and Val32, displayed significantly decreased levels of enzyme activity when compared with that of the 'wild-type' enzyme, while the level of activity of the His253 allozyme was similar to that of the wildtype enzyme (Figure 2 ). All of these data were corrected for transfection efficiency. The Asp22Tyr polymorphism resulted in a reduction in enzyme activity of approximately 90%, while the Ala32Val polymorphism resulted in a 42% reduction (Figure 2 ). These observations raised the question of mechanism(s) responsible for differences in basal levels of enzyme activity.
One possible mechanism responsible for decreased level of enzyme activity would involve a decrease in the quantity of enzyme protein. Therefore, recombinant cytosol preparations from six independent transfections for each allozyme were subjected to quantitative Western blot analysis. The sequence of the peptide used to generate the rabbit polyclonal antibody The 12 unambiguous haplotypes -those labeled *1 -observed in the 120 DNA samples resequenced are listed. Sequence within each of the alleles that differed from the SULT1E1 consensus sequence (*1C) has been shown as white type against a black background. Initial designations of haplotypes were made on the basis of the encoded amino-acid sequence, with the wild-type sequence being designated *1. 'Letter' designations were then added based on descending allele frequencies, starting with haplotypes present in both ethnic groups and then making assignments based on haplotypes observed in samples from African-American subjects. Although we were unable to determine their haplotypes unequivocally, we have also listed the Tyr22 variant as *2, the Val32 variant as *3 and the His253 as *4. used to perform these Western blot analyses did not include any of the amino acids changed in the variant SULT1E1 allozymes . Average levels of immunoreactive SULT1E1 protein, corrected for transfection efficiency, paralleled relative levels of enzyme activity for all the three of the variant allozymes (Figures 2 and 3) . A representative Western blot with two different exposure times, 10 and 60 s, is shown in Figure 3b . Immunoreactive protein for the Tyr22 allozyme could only be detected after the longer exposure time (Figure 3b ). These observations represent additional evidence that the alteration of only a single amino acid as a result of a genetic polymorphism can significantly alter the level of enzyme protein.
Recombinant allozyme substrate kinetics and thermal stability
Enzyme kinetic properties could also be affected by changes in amino-acid sequence. Therefore, we determined apparent K m values for each of the recombinant SULT1E1 allozymes with both E2 and PAPS as substrates. Since SULTs can display profound substrate inhibition by the sulfate acceptor cosubstrate (Weinshilboum & Otterness, 1994) , these experiments were conducted in two stages. During the first series of studies, a wide range of substrate concentrations was tested. In the second set of experiments, based on the results of the initial studies, the concentration range was narrowed to values appropriate for the determination of apparent K m values, but no data points that displayed substrate inhibition were used to calculate these values. There were statistically significant differences among SULT1E1 allozymes in apparent K m values for both E2 and PAPS (Table 5) . As a result, the decreased level of basal enzyme activity for the Tyr22 allozyme could be attributed both to alterations in level of enzyme protein and to alterations in substrate kinetics -but predominantly to decreased protein (Figures 2, 3 and Table 5 ). However, substrate kinetics for the Val32 allozyme were only slightly different from those the wild-type enzyme. Therefore, the decrease in level of enzyme activity for that allozyme appeared to result primarily from the decreased level of immunoreactive protein.
Although there were no differences in levels of either enzyme activity or immunoreactive protein for the His253 allozyme, that allozyme did display significant increases in both K m and V max values when compared with the wild-type enzymedifferences that may have 'offset' each other in their effect on level of enzyme activity. The apparent K m values of wild-type SULT1E1 for E2 and PAPS that we determined fell within the range of values that have been reported previously by other authors (Zhang et al., 1998; Fujita et al., 1999; Hempel et al., 2000; Otake et al., 2000; Pedersen et al., 2002) . That was encouraging since our studies, unlike those for several previous reports, used cytosol preparations rather than purified SULT1E1 to determine kinetic constants. Finally, studies of variant allozymes for other enzymes have shown that decreased levels of enzyme protein as a result of genetic polymorphisms have often shown an association with decreased enzyme thermal stability (Scanlon et al., 1979; Kang et al., 1991; Raftogianis et al., 1997; Preuss et al., 1998; Shield & Weinshilboum, 2002) . Therefore, we assayed the thermal stability of SULT1E1 allozymes. When T 50 values, the temperature at which the enzyme was 50% inactivated, were determined, the Tyr22 and Val32 allozymes both showed reduced T 50 values when compared with the wild-type enzyme -although the decrease for the Val32 allozyme was not statistically significant (Table 5) .
SULT1E1 polymorphisms and crystal structures: The X-ray crystal structure of mouse SULT1E1 has been solved in the presence of 3 0 -phosphoadenosine 5 0 -phosphate at a resolution of 2.5 Å (Kakuta et al., 1997) . Recently, Pedersen et al. (2002) also solved the crystal structure of human SULT1E1 and reported that the substrate-binding pocket of human SULT1E1 is very similar to that of the mouse enzyme. Figure 4 depicts the human SULT1E1 structure determined by X-ray crystallography, with locations of the polymorphisms that we observed indicated in relation to known substratebinding regions of the enzyme. The Asp22Tyr polymorphism that we observed was located 14 residues downstream from the conserved SULT 'Region I' sequence motif (Weinshilboum & Otterness, 1994; Varin et al., 1995; Weinshilboum et al., 1997) , the E2 substrate-binding region. This residue was located at the entrance to the substrate-binding pocket. Therefore, this change in amino acid from one with a polar to one with an acidic side chain could potentially influence access of the substrate to the active site -a possible explanation for the increase in apparent K m value which we observed (Table 5 ). In contrast, the Ala32Val polymorphism involved two residues with hydrophobic side chains. This alteration in amino acid resulted in both decreased enzyme activity and decreased immunoreactive protein (Figures 2 and 3 ), but without a substantial effect on substrate kinetics. On the basis of the X-ray crystal structure, this amino acid was located on the surface the protein outside the putative substrate-binding site. The third change in amino acid, Pro253His, was located three amino acids upstream of the 'Region IV' conserved SULT sequence motif, the PAPS-binding site (Weinshilboum & Otterness, 1994; Varin et al., 1995; Weinshilboum et al., 1997) . This final polymorphism resulted in a two-to three-fold increase in K m and V max values for E2, while the K m for PAPS increased approximately three-fold, but with only a slight increase in V max (Table 5) . Although this slight increase in V max was statistically significant, its in vivo functional significance remains to be determined.
Discussion
Estrogens are used as drugs -especially in postmenopausal hormone replacement therapy (Barratt-Connor & Grady, 1998) . In addition, epidemiologic studies have shown repeatedly that cumulative lifetime exposure to estrogen is an important risk factor for breast cancer (Colditz, 1997) . Estrogen inactivation in humans occurs, in part, as a result of sulfate conjugation catalyzed by SULTs, with SULT1E1 having the lowest K m values of known human SULT isoforms for these steroid hormones (Hobkirk, 1993; Aksoy et al., 1994; Falany et al., 1995; Strott, 1996; Adjei & Weinshilboum, 2002) . SULT1E1 also catalyzes the sulfate conjugation of catecholestrogens, 2-methoxyestradiol (an experimental antineoplastic agent) and other structurally related steroids (Aksoy et al., 1994; Falany et al., 1995; Adjei et al., 2001; Adjei & Weinshilboum, 2002) . Many human SULTs are genetically polymorphic, and those polymorphisms can be functionally significant Freimuth et al., 2001; Thomae et al., 2002) -raising the possibility that SULT1E1 might also display genetically mediated variation in function. Therefore, we set out to determine whether SULT1E1 might have genetic polymorphisms, whether those polymorphisms might differ among ethnic groups and whether they might have functional implications. We began by resequencing the eight exons, intron sequence flanking those exons and a portion of the 5 0 -flanking region of the gene using DNA samples from African-American and Caucasian-American subjects. In all, 23 polymorphisms, including three nonsynonymous cSNPs, were observed in the 120 DNA samples (240 alleles) resequenced. There were more SNPs in African-American DNA samples than in the samples from Caucasian-American subjects (Table 2, Figure 1 ). This observation is compatible with previous reports of greater DNA sequence diversity in African populations than in other ethnic groups (Kaessmann et al., 1999; Thomae et al., 2002; Tishkoff & Williams, 2002) . Several of the SULT1E1 polymorphisms were tightly linked (Table 3) , and a series of unambiguous haplotypes were observed in both populations (Table 4) . Expression constructs were then created for the three nonsynonymous SULT1E1 cSNPs observed, and those constructs were used to transfect COS-1 cells transiently. The His253 and wild-type allozymes were similar with respect to levels of basal activity and immunoreactive protein (Figures  2 and 3) . However, there were decreases in basal levels of enzyme activity for variant allozymes Tyr22 and Val32, decreases that were associated with decreased levels of immunoreactive protein (Figures 2 and 3) . Furthermore, the thermal stability of the Tyr22 and Val32 was decreased (Table 4 ). These decreases in thermal stability may be associated with alterations in protein folding (Wang & Moult, 2001 ) -a hypothesis that will have to be pursued in the course of future studies. Finally, substrate kinetic studies showed that apparent K m values for E2 and PAPS also varied among allozymes (Table 5) . In summary, we have detected and functionally characterized genetic variation in the human SULT1E1 gene. Although the three nonsynonymous cSNPs that we observed occurred relatively infrequently and, therefore, might represent mutations rather than polymorphisms (Table 2) , functional genomic studies showed that two of them resulted in significant decreases in both levels of enzyme activity and quantity of enzyme protein (Figures 2 and 3) . In addition, allozymes encoded by these variant alleles also displayed alterations in substrate kinetics (Table 5 ). The in vivo functional implications of these observations remain to be determined, as do the possible functional consequences of the other polymorphisms that we observed. The recent observation that disruption of the SULT1E1 gene in mice results in male infertility (Qian et al., 2001 ) raises the question of whether a similar phenomenon might occur in humans. For example, an individual homozygous for the Tyr22 allozyme might be at risk for this phenotype -although that possibility is purely speculative in the absence of the identification and study of such subjects. Estrogen exposure is also a major risk factor for hormonedependent neoplasia such as breast cancer (Henderson & Bernstein, 1996) . Therefore, future studies might focus on these variants as risk factors for both reproductive disorders and hormone-dependent cancer. The present study also represents an example of the way in which a genotype-tophenotype strategy can be used to discover genetic polymorphisms and test their functional significance. Finally, our results raise the possibility that ethnic-specific genetic variation in SULT1E1 -a gene encoding an estrogen-metabolizing enzyme -may contribute to individual differences in the biotransformation of this steroid hormone. If that proves to be the case in vivo, these 'pharmacogenetic' variations could contribute to individual differences in lifetime estrogen exposure as well as variation in the metabolism and, thus, the effect of exogenously administered estrogens.
